Foundry DelCOA Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1SNOW | SNOWFLAKE INC | Technology | $93.20B | 8.58% |
2NDAQ | NASDAQ INC | Financial Services | $51.83B | 4.77% |
3AXON | AXON ENTERPRISE INC | Industrials | $41.13B | 3.78% |
4RVMD | REVOLUTION MEDICINES INC | Healthcare | $39.58B | 3.64% |
5WDAY | WORKDAY INC | Technology | $35.76B | 3.29% |
6HSY | HERSHEY CO | Consumer Defensive | $34.77B | 3.20% |
7DXCM | DEXCOM INC | Healthcare | $29.58B | 2.72% |
8ECHO | ECHO GLOBAL LOGISTICS INC | Industrials | $26.66B | 2.45% |
9CPRT | COPART INC | Industrials | $25.56B | 2.35% |
10VRSN | VERISIGN INC | Technology | $25.27B | 2.33% |
11MDB | MONGODB INC | Technology | $25.12B | 2.31% |
12MRNA | MODERNA INC | Healthcare | $24.53B | 2.26% |
13DLTR | DOLLAR TREE INC | Consumer Defensive | $24.20B | 2.23% |
14FSLR | FIRST SOLAR INC | Technology | $22.78B | 2.10% |
15UTHR | UNITED THERAPEUTICS CORP | Healthcare | $22.74B | 2.09% |
16ASTS | AST SPACEMOBILE INC | Technology | $22.43B | 2.06% |
17RIVN | RIVIAN AUTOMOTIVE INC | Consumer Cyclical | $22.00B | 2.02% |
18IFF | INTERNATIONAL FLAVORS & FRAGRANCES INC | Basic Materials | $19.96B | 1.84% |
19FTV | FORTIVE CORP | Technology | $18.83B | 1.73% |
20NWSA | NEWS CORP | Communication Services | $15.56B | 1.43% |
21DECK | DECKERS OUTDOOR CORP | Consumer Cyclical | $14.79B | 1.36% |
22ONTO | ONTO INNOVATION INC | Technology | $13.92B | 1.28% |
23BTSG | BRIGHTSPRING HEALTH SERVICES INC | Healthcare | $13.71B | 1.26% |
24PINS | PINTEREST INC | Communication Services | $13.00B | 1.20% |
25COKE | COCA-COLA CONSOLIDATED INC | Consumer Defensive | $12.03B | 1.11% |
26AUR | AURORA INNOVATION INC | Technology | $11.88B | 1.09% |
27BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | $11.52B | 1.06% |
28HUBS | HUBSPOT INC | Technology | $11.49B | 1.06% |
29HUT | HUT 8 CORP | Financial Services | $10.30B | 0.95% |
30CYTK | CYTOKINETICS INC | Healthcare | $9.98B | 0.92% |
31HALO | HALOZYME THERAPEUTICS INC | Healthcare | $9.23B | 0.85% |
32PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | $9.06B | 0.83% |
33WULF | TERAWULF INC | Financial Services | $9.00B | 0.83% |
34TTC | TORO CO | Industrials | $8.99B | 0.83% |
35ZG | ZILLOW GROUP INC | Communication Services | $7.71B | 0.71% |
36DBX | DROPBOX INC | Technology | $7.14B | 0.66% |
37IDCC | INTERDIGITAL INC | Communication Services | $6.73B | 0.62% |
38VFC | V F CORP | Consumer Cyclical | $6.65B | 0.61% |
39NE | NOBLE CORP PLC | Energy | $6.62B | 0.61% |
40RYN | RAYONIER INC | Real Estate | $6.56B | 0.60% |
41LUMN | LUMEN TECHNOLOGIES INC | Communication Services | $6.47B | 0.60% |
42SRRK | SCHOLAR ROCK HOLDING CORP | Healthcare | $6.33B | 0.58% |
43PATH | UIPATH INC | Technology | $6.30B | 0.58% |
44MYRG | MYR GROUP INC | Industrials | $6.10B | 0.56% |
45RUSHA | RUSH ENTERPRISES INC | Consumer Cyclical | $5.98B | 0.55% |
46ERAS | ERASCA INC | Healthcare | $5.96B | 0.55% |
47LYFT | LYFT INC | Technology | $5.89B | 0.54% |
48ENPH | ENPHASE ENERGY INC | Technology | $5.48B | 0.50% |
49DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | $4.83B | 0.44% |
50IPGP | IPG PHOTONICS CORP | Technology | $4.43B | 0.41% |
51VKTX | VIKING THERAPEUTICS INC | Healthcare | $4.31B | 0.40% |
52PI | IMPINJ INC | Technology | $4.21B | 0.39% |
53ACLS | AXCELIS TECHNOLOGIES INC | Technology | $4.19B | 0.39% |
54MAT | MATTEL INC | Consumer Cyclical | $4.15B | 0.38% |
55ICUI | ICU MEDICAL INC | Healthcare | $3.94B | 0.36% |
56DOCS | DOXIMITY INC | Healthcare | $3.94B | 0.36% |
57POWI | POWER INTEGRATIONS INC | Technology | $3.93B | 0.36% |
58TDS | TELEPHONE & DATA SYSTEMS INC | Communication Services | $3.90B | 0.36% |
59RLAY | RELAY THERAPEUTICS INC | Healthcare | $3.81B | 0.35% |
60OLED | UNIVERSAL DISPLAY CORP | Technology | $3.75B | 0.34% |
61DNLI | DENALI THERAPEUTICS INC | Healthcare | $3.70B | 0.34% |
62CALY | CALLAWAY GOLF CO | Consumer Cyclical | $3.48B | 0.32% |
63RCUS | ARCUS BIOSCIENCES INC | Healthcare | $3.44B | 0.32% |
64QTWO | Q2 HOLDINGS INC | Technology | $3.43B | 0.32% |
65SEDG | SOLAREDGE TECHNOLOGIES INC | Technology | $3.25B | 0.30% |
66COLM | COLUMBIA SPORTSWEAR CO | Consumer Cyclical | $3.25B | 0.30% |
67LEU | CENTRUS ENERGY CORP | Basic Materials | $3.07B | 0.28% |
68AD | ARRAY DIGITAL INFRASTRUCTURE INC | Communication Services | $3.02B | 0.28% |
69FRSH | FRESHWORKS INC | Technology | $3.01B | 0.28% |
70RARE | ULTRAGENYX PHARMACEUTICAL INC | Healthcare | $2.88B | 0.27% |
71DAN | DANA INC | Consumer Cyclical | $2.87B | 0.26% |
72LCID | LUCID GROUP INC | Consumer Cyclical | $2.87B | 0.26% |
73HOG | HARLEY-DAVIDSON INC | Consumer Cyclical | $2.80B | 0.26% |
74CLDX | CELLDEX THERAPEUTICS INC | Healthcare | $2.77B | 0.26% |
75VERA | VERA THERAPEUTICS INC | Healthcare | $2.76B | 0.25% |
76TNET | TRINET GROUP INC | Industrials | $2.74B | 0.25% |
77VISN | VISTANCE NETWORKS INC | Technology | $2.74B | 0.25% |
78PTON | PELOTON INTERACTIVE INC | Consumer Cyclical | $2.55B | 0.23% |
79IMNM | IMMUNOME INC | Healthcare | $2.53B | 0.23% |
80PGNY | PROGYNY INC | Healthcare | $2.50B | 0.23% |
81NRIX | NURIX THERAPEUTICS INC | Healthcare | $2.40B | 0.22% |
82BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | $2.36B | 0.22% |
83AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | $2.36B | 0.22% |
84BHVN | BIOHAVEN LTD | Healthcare | $2.32B | 0.21% |
85IOVA | IOVANCE BIOTHERAPEUTICS INC | Healthcare | $2.23B | 0.21% |
86SION | SIONNA THERAPEUTICS INC | Healthcare | $2.23B | 0.21% |
87AGL | AGILON HEALTH INC | Healthcare | $2.17B | 0.20% |
88PPTA | PERPETUA RESOURCES CORP | Basic Materials | $2.11B | 0.19% |
89CDNA | CAREDX INC | Healthcare | $2.05B | 0.19% |
90SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | $2.02B | 0.19% |
91AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | $1.97B | 0.18% |
92CPRI | CAPRI HOLDINGS LTD | Consumer Cyclical | $1.89B | 0.17% |
93MQ | MARQETA INC | Technology | $1.85B | 0.17% |
94NVCR | NOVOCURE LTD | Healthcare | $1.84B | 0.17% |
95SRPT | SAREPTA THERAPEUTICS INC | Healthcare | $1.82B | 0.17% |
96BL | BLACKLINE INC | Technology | $1.78B | 0.16% |
97ASAN | ASANA INC | Technology | $1.77B | 0.16% |
98ZYME | ZYMEWORKS INC | Healthcare | $1.77B | 0.16% |
99ANAB | ANAPTYSBIO INC | Healthcare | $1.69B | 0.16% |
100FTRE | FORTREA HOLDINGS INC | Healthcare | $1.68B | 0.15% |
101TE | T1 ENERGY INC | Industrials | $1.63B | 0.15% |
102INVA | INNOVIVA INC | Healthcare | $1.60B | 0.15% |
103VIR | VIR BIOTECHNOLOGY INC | Healthcare | $1.59B | 0.15% |
104NTLA | INTELLIA THERAPEUTICS INC | Healthcare | $1.59B | 0.15% |
105INSP | INSPIRE MEDICAL SYSTEMS INC | Healthcare | $1.46B | 0.13% |
106TRS | TRIMAS CORP | Consumer Cyclical | $1.46B | 0.13% |
107MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | $1.45B | 0.13% |
108ARLO | ARLO TECHNOLOGIES INC | Basic Materials | $1.45B | 0.13% |
109YELP | YELP INC | Communication Services | $1.44B | 0.13% |
110HLX | HELIX ENERGY SOLUTIONS GROUP INC | Energy | $1.41B | 0.13% |
111FMC | FMC CORP | Basic Materials | $1.40B | 0.13% |
112AI | C3AI INC | Technology | $1.37B | 0.13% |
113CXM | SPRINKLR INC | Technology | $1.37B | 0.13% |
114BW | BABCOCK & WILCOX ENTERPRISES INC | Industrials | $1.35B | 0.12% |
115FCEL | FUELCELL ENERGY INC | Industrials | $1.25B | 0.12% |
116CMP | COMPASS MINERALS INTERNATIONAL INC | Basic Materials | $1.24B | 0.11% |
117MMI | MARCUS & MILLICHAP INC | Real Estate | $1.18B | 0.11% |
118SDGR | SCHRODINGER INC | Healthcare | $1.14B | 0.11% |
119CRTO | CRITEO SA | Communication Services | $1.13B | 0.10% |
120UPWK | UPWORK INC | Industrials | $1.12B | 0.10% |
121EYPT | EYEPOINT INC | Healthcare | $1.12B | 0.10% |
122PCRX | PACIRA BIOSCIENCES INC | Healthcare | $1.01B | 0.09% |
123KURA | KURA ONCOLOGY INC | Healthcare | $964M | 0.09% |
124ANNX | ANNEXON INC | Healthcare | $950M | 0.09% |
125WGO | WINNEBAGO INDUSTRIES INC | Consumer Cyclical | $868M | 0.08% |
126REPL | REPLIMUNE GROUP INC | Healthcare | $859M | 0.08% |
127MATW | MATTHEWS INTERNATIONAL CORP | Industrials | $857M | 0.08% |
128CYRX | CRYOPORT INC | Industrials | $832M | 0.08% |
129CODI | COMPASS DIVERSIFIED HOLDINGS | Industrials | $777M | 0.07% |
130WLKP | WESTLAKE CHEMICAL PARTNERS LP | Basic Materials | $776M | 0.07% |
131BBNX | BETA BIONICS INC | Healthcare | $771M | 0.07% |
132KRO | KRONOS WORLDWIDE INC | Basic Materials | $757M | 0.07% |
133IBTA | IBOTTA INC | Technology | $734M | 0.07% |
134AURA | AURA BIOSCIENCES INC | Healthcare | $723M | 0.07% |
135SPRY | ARS PHARMACEUTICALS INC | Healthcare | $695M | 0.06% |
136PKE | PARK AEROSPACE CORP | Industrials | $677M | 0.06% |
137SWBI | SMITH & WESSON BRANDS INC | Industrials | $665M | 0.06% |
138MNTN | MNTN INC | Technology | $661M | 0.06% |
139CNNE | CANNAE HOLDINGS INC | Consumer Cyclical | $657M | 0.06% |
140EVH | EVOLENT HEALTH INC | Healthcare | $654M | 0.06% |
141ACHV | ACHIEVE LIFE SCIENCES INC | Healthcare | $644M | 0.06% |
142HY | HYSTER-YALE INC | Industrials | $591M | 0.05% |
143PUBM | PUBMATIC INC | Technology | $591M | 0.05% |
144NGNE | NEUROGENE INC | Healthcare | $590M | 0.05% |
145ETD | ETHAN ALLEN INTERIORS INC | Consumer Cyclical | $580M | 0.05% |
146MLR | MILLER INDUSTRIES INC | Consumer Cyclical | $566M | 0.05% |
147EGY | VAALCO ENERGY INC | Energy | $553M | 0.05% |
148WNC | WABASH NATIONAL CORP | Industrials | $547M | 0.05% |
149ORN | ORION GROUP HOLDINGS INC | Industrials | $518M | 0.05% |
150ARVN | ARVINAS INC | Healthcare | $517M | 0.05% |
151SPIR | SPIRE GLOBAL INC | Industrials | $488M | 0.04% |
152SGMT | SAGIMET BIOSCIENCES INC | Healthcare | $479M | 0.04% |
153TITN | TITAN MACHINERY INC | Industrials | $446M | 0.04% |
154SRTA | STRATA CRITICAL MEDICAL INC | Industrials | $446M | 0.04% |
155BNED | BARNES & NOBLE EDUCATION INC | Consumer Cyclical | $437M | 0.04% |
156CCRN | CROSS COUNTRY HEALTHCARE INC | Healthcare | $428M | 0.04% |
157ASPN | ASPEN AEROGELS INC | Basic Materials | $425M | 0.04% |
158CLFD | CLEARFIELD INC | Technology | $416M | 0.04% |
159MCFT | MASTERCRAFT BOAT HOLDINGS INC | Consumer Cyclical | $407M | 0.04% |
160ENTA | ENANTA PHARMACEUTICALS INC | Healthcare | $400M | 0.04% |
161EBS | EMERGENT BIOSOLUTIONS INC | Healthcare | $394M | 0.04% |
162VHI | VALHI INC | Basic Materials | $393M | 0.04% |
163STRO | SUTRO BIOPHARMA INC | Healthcare | $391M | 0.04% |
164UPB | UPSTREAM BIO INC | Healthcare | $382M | 0.04% |
165WEYS | WEYCO GROUP INC | Consumer Cyclical | $374M | 0.03% |
166ZNTL | ZENTALIS PHARMACEUTICALS INC | Healthcare | $364M | 0.03% |
167STRT | STRATTEC SECURITY CORP | Consumer Cyclical | $344M | 0.03% |
168MTRX | MATRIX SERVICE CO | Industrials | $342M | 0.03% |
169RTAC | RENATUS TACTICAL ACQUISITION CORP I | Industrials | $329M | 0.03% |
170VNDA | VANDA PHARMACEUTICALS INC | Healthcare | $327M | 0.03% |
171MSB | MESABI TRUST | Basic Materials | $320M | 0.03% |
172VELO | VELO3D INC | Technology | $316M | 0.03% |
173MKTW | MARKETWISE INC | Technology | $314M | 0.03% |
174OSS | ONE STOP SYSTEMS INC | Technology | $313M | 0.03% |
175BKTI | BK TECHNOLOGIES CORP | Technology | $307M | 0.03% |
176FHTX | FOGHORN THERAPEUTICS INC | Healthcare | $305M | 0.03% |
177ALCO | ALICO INC | Consumer Defensive | $304M | 0.03% |
178TKNO | ALPHA TEKNOVA INC | Healthcare | $291M | 0.03% |
179ASLE | AERSALE CORP | Industrials | $286M | 0.03% |
180TSSI | TSS INC | Technology | $274M | 0.03% |
181AVNW | AVIAT NETWORKS INC | Technology | $269M | 0.02% |
182TRDA | ENTRADA THERAPEUTICS INC | Healthcare | $268M | 0.02% |
183ALMU | AELUMA INC | Technology | $267M | 0.02% |
184SVCO | SILVACO GROUP INC | Technology | $260M | 0.02% |
185TBCH | TURTLE BEACH CORP | Technology | $258M | 0.02% |
186VNME | VENDOME ACQUISITION CORP I | Industrials | $254M | 0.02% |
187ARTV | ARTIVA BIOTHERAPEUTICS INC | Healthcare | $241M | 0.02% |
188QUIK | QUICKLOGIC CORP | Technology | $237M | 0.02% |
189ONEW | ONEWATER MARINE INC | Consumer Cyclical | $224M | 0.02% |
190KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | $216M | 0.02% |
191KROS | KEROS THERAPEUTICS INC | Healthcare | $211M | 0.02% |
192ALTG | ALTA EQUIPMENT GROUP INC | Industrials | $208M | 0.02% |
193SRI | STONERIDGE INC | Consumer Cyclical | $197M | 0.02% |
194COOK | TRAEGER INC | Consumer Cyclical | $193M | 0.02% |
195EAF | GRAFTECH INTERNATIONAL LTD | Industrials | $181M | 0.02% |
196KVHI | KVH INDUSTRIES INC | Technology | $178M | 0.02% |
197LEE | LEE ENTERPRISES INC | Consumer Cyclical | $175M | 0.02% |
198ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | Healthcare | $172M | 0.02% |
199RCEL | AVITA MEDICAL INC | Healthcare | $157M | 0.01% |
200HOFT | HOOKER FURNISHINGS CORP | Consumer Cyclical | $152M | 0.01% |
201CHPT | CHARGEPOINT HOLDINGS INC | Consumer Cyclical | $146M | 0.01% |
202ACNT | ASCENT INDUSTRIES CO | Basic Materials | $138M | 0.01% |
203PMN | PROMIS NEUROSCIENCES INC | Healthcare | $136M | 0.01% |
204DMRC | DIGIMARC CORP | Technology | $133M | 0.01% |
205AARD | AARDVARK THERAPEUTICS INC | Healthcare | $128M | 0.01% |
206JYNT | JOINT CORP | Healthcare | $127M | 0.01% |
207VATE | INNOVATE CORP | Industrials | $123M | 0.01% |
208SPRB | SPRUCE BIOSCIENCES INC | Healthcare | $120M | 0.01% |
209UFI | UNIFI INC | Consumer Cyclical | $118M | 0.01% |
210SSTI | SOUNDTHINKING INC | Technology | $111M | 0.01% |
211MHH | MASTECH DIGITAL INC | Industrials | $89M | 0.01% |
212GEOS | GEOSPACE TECHNOLOGIES CORP | Energy | $88M | 0.01% |
213RLYB | RALLYBIO CORP | Healthcare | $87M | 0.01% |
214DLHC | DLH HOLDINGS CORP | Industrials | $80M | 0.01% |
215LFVN | LIFEVANTAGE CORP | Consumer Defensive | $78M | 0.01% |
216ACET | ADICET BIO INC | Healthcare | $76M | 0.01% |
217ATRA | ATARA BIOTHERAPEUTICS INC | Healthcare | $76M | 0.01% |
218BODI | BEACHBODY COMPANY INC | Communication Services | $75M | 0.01% |
219TISI | TEAM INC | Industrials | $75M | 0.01% |
220BGSF | BGSF INC | Industrials | $65M | 0.01% |
221BRID | BRIDGFORD FOODS CORP | Consumer Defensive | $59M | 0.01% |
222LNZA | LANZATECH GLOBAL INC | Industrials | $56M | 0.01% |
223TACT | TRANSACT TECHNOLOGIES INC | Technology | $54M | 0.00% |
224ACFN | ACORN ENERGY INC | Technology | $51M | 0.00% |
225TIL | INSTIL BIO INC | Healthcare | $50M | 0.00% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $1.09T. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 88% toward Large, 68% toward Growth. +15% unclassified (27 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → July 2026; the right-hand end is the same value as the box’s dot. 225 names now. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
Days required to liquidate the largest position at 20% of one day's dollar volume.
Required<= 7.0 daysActualunboundedMargin—
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 225 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months
The estimators agree, which is mild evidence the number isn’t an artefact of one method.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
Annual return moved the other way (+0.6pp), so Sharpe and return disagree here — the change is partly a shift in volatility rather than in return.
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 23.0% | 3.2% |
| 3 yearsp.a. | 15.4% | -18.2% |
| 5 yearsp.a. | 10.9% | -8.8% |
| 10 yearsp.a. | 14.9% | -8.9% |
| Since inceptionp.a. | 9.7% | -5.5% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | 16.8% | 10.2% |
| 2025 | 19.1% | -23.2% |
| 2024 | 6.5% | -38.5% |
| 2023 | 62.1% | 15.5% |
| 2022 | -29.3% | 13.8% |
| 2021 | 21.3% | -6.1% |
| 2020 | 36.2% | -15.8% |
| 2019 | 25.9% | -6.5% |
| 2018 | -10.6% | -10.7% |
| 2017 | 17.9% | -17.9% |
| 2016 | 23.7% | 18.9% |
| 2015 | -4.5% | -6.1% |
| 2014 | 11.2% | -6.2% |
| 2013 | 41.4% | -8.5% |
| 2012 | 17.5% | 12.4% |
| 2011 | 3.6% | 4.7% |
| 2010 | 19.7% | 9.5% |
| 2009 | 39.9% | -14.6% |
| 2008 | -38.4% | 16.8% |
| 2007 | 8.3% | -23.1% |
| 2006 | 19.2% | -3.9% |
| 2005 | 0.3% | -11.9% |
| 2004 | 3.3% | -10.9% |
| 2003 | 54.4% | 14.4% |
| 2002 | -41.0% | -23.5% |
| 2001 | -15.5% | -7.3% |
| 2000 | -4.7% | 21.6% |
| 1999 | 52.6% | -19.1% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry DelCOA Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a DelCOA signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.